BioNexus Gene Lab Corp [NASDAQ: BGLC] surged by $0.03 during the normal trading session on while it closed the day at $0.39.
BioNexus Gene Lab Corp stock has also loss -7.84% of its value over the past 7 days. However, BGLC stock has declined by -18.09% in the 3 months of the year. Over the past six months meanwhile, it has lost -45.38% and lost -26.60% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for BGLC stock reached $6.99 million, with 17.67 million shares outstanding and 8.19 million shares in the current float. Compared to the average trading volume of 139.36K shares, BGLC reached a trading volume of 12157150 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about BioNexus Gene Lab Corp [BGLC]:
The Average True Range (ATR) for BioNexus Gene Lab Corp is set at 0.06, with the Price to Sales ratio for BGLC stock in the period of the last 12 months amounting to 0.76. The Price to Book ratio for the last quarter was 0.72, with the Price to Cash per share for the same quarter was set at 0.30.
BGLC stock trade performance evaluation
BioNexus Gene Lab Corp [BGLC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.84. With this latest performance, BGLC shares dropped by -12.58% in over the last four-week period, additionally sinking by -45.38% over the last 6 months – not to mention a drop of -62.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BGLC stock in for the last two-week period is set at 41.58, with the RSI for the last a single of trading hit 42.11, and the three-weeks RSI is set at 41.93 for BioNexus Gene Lab Corp [BGLC]. The present Moving Average for the last 50 days of trading for this stock 0.4548, while it was recorded at 0.3780 for the last single week of trading, and 0.5773 for the last 200 days.
BioNexus Gene Lab Corp [BGLC]: An insightful look at the core fundamentals
BioNexus Gene Lab Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.87 and a Current Ratio set at 5.60.
